dapsone has been researched along with cycloguanil in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (28.57) | 18.7374 |
| 1990's | 5 (35.71) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Genther, CS; Smith, CS | 1 |
| Queener, SF | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| González-Ruiz, A; Haworth, SJ; O'Neil, AB; Warhurst, DC | 1 |
| Edstein, MD; Rieckmann, KH; Veenendaal, JR | 1 |
| Berlin, OG; Bruckner, DA; Gonzalez, AH | 1 |
| O'Sullivan, WJ; Rieckmann, KH; Scott, HV | 1 |
| Rossan, RN; Schmidt, LH | 1 |
| Edstein, MD; Rieckmann, KH; Shanks, GD; Teja-Isavadharm, P; Webster, HK | 1 |
| Edstein, MD; Rieckmann, KH; Shanks, GD; Yeo, AE | 1 |
| Peters, W; Robinson, BL; Stewart, LB | 1 |
| Hunt, S; Kamau, EM; Nduati, E; Nzila, A | 1 |
| Kamau, EM; Nduati, EW | 1 |
| Aarons, L; Bojang, K; Edwards, G; Hughes, D; Manyando, C; Simpson, JA; Ward, S; Watkins, WA; Winstanley, P | 1 |
1 review(s) available for dapsone and cycloguanil
| Article | Year |
|---|---|
New drug developments for opportunistic infections in immunosuppressed patients: Pneumocystis carinii.
Topics: Animals; Drug Design; Humans; Immunosuppression Therapy; Molecular Structure; Opportunistic Infections; Pneumonia, Pneumocystis; Structure-Activity Relationship | 1995 |
13 other study(ies) available for dapsone and cycloguanil
| Article | Year |
|---|---|
Antifolate studies. Activities of 40 potential antimalarial compounds against sensitive and chlorguanide triazine resistant strains of folate-requiring bacteria and Escherichia coli.
Topics: Animals; Antimalarials; Bacteria; Drug Resistance, Microbial; Escherichia coli; Folic Acid; Folic Acid Antagonists; Malaria; Mice; Plasmodium berghei; Triazines | 1977 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Dapsone in low doses prevents Pneumocystis carinii pneumonia in the rat model.
Topics: Administration, Oral; Animals; Dapsone; Diet; Disease Models, Animal; Immune Tolerance; Male; Pneumonia, Pneumocystis; Proguanil; Random Allocation; Rats; Rats, Inbred Strains; Triazines | 1991 |
Multiple-dose kinetics in healthy volunteers and in vitro antimalarial activity of proguanil plus dapsone.
Topics: Adult; Animals; Anti-Infective Agents; Dapsone; Drug Administration Schedule; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Half-Life; Humans; Male; Plasmodium falciparum; Proguanil; Time Factors; Triazines | 1990 |
In-vitro activity of dapsone and two potentiators against Mycobacterium avium complex.
Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Dapsone; Drug Synergism; Humans; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Proguanil; Sulfamethazine; Triazines | 1989 |
Synergistic antimalarial activity of dapsone/dihydrofolate reductase inhibitors and the interaction of antifol, antipyrimidine and antipurine combinations against Plasmodium falciparum in vitro.
Topics: Animals; Antimalarials; Antimetabolites; Dapsone; Drug Synergism; Plasmodium falciparum; Proguanil; Ribonucleosides; Triazines | 1987 |
Activities of respository preparations of cycloguanil pamoate and 4,4'-diacetyldiaminodiphenylsulfone, alone and in combination, against infections with Plasmodium cynomolgi in rhesus monkeys.
Topics: Acedapsone; Animals; Antimalarials; Dapsone; Drug Combinations; Drug Resistance, Microbial; Macaca mulatta; Malaria; Particle Size; Plasmodium falciparum; Plasmodium vivax; Proguanil; Pyrimethamine; Time Factors; Triazines | 1984 |
Oxidative activation of proguanil and dapsone acetylation in Thai soldiers.
Topics: Acetylation; Biotransformation; Chromatography, High Pressure Liquid; Dapsone; Humans; Malaria; Military Personnel; Oxidation-Reduction; Polymorphism, Genetic; Proguanil; Thailand; Triazines | 1994 |
Ex vivo antimalarial activity of proguanil combined with dapsone against cycloguanil-resistant Plasmodium falciparum isolates.
Topics: Animals; Antimalarials; Dapsone; Drug Resistance; Drug Therapy, Combination; Humans; Malaria, Falciparum; Plasmodium falciparum; Proguanil; Triazines | 1997 |
The chemotherapy of rodent malaria. LXII. Drug combinations to impede the selection of drug resistance, part 5: rates of development of resistance to some inhibitors of folate metabolism and to artesunate.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Dapsone; Drug Resistance; Drug Therapy, Combination; Folic Acid Antagonists; Malaria, Falciparum; Male; Mice; Parasitemia; Plasmodium berghei; Plasmodium chabaudi; Plasmodium yoelii; Proguanil; Sesquiterpenes; Triazines | 2004 |
2,4-diaminopteridine-based compounds as precursors for de novo synthesis of antifolates: a novel class of antimalarials.
Topics: Animals; Antimalarials; Dapsone; Dihydropteroate Synthase; Drug Combinations; Drug Synergism; Folic Acid Antagonists; Plasmodium; Proguanil; Pteridines; Saccharomyces cerevisiae; Tetrahydrofolate Dehydrogenase; Triazines | 2005 |
Multiple synergistic interactions between atovaquone and antifolates against Plasmodium falciparum in vitro: a rational basis for combination therapy.
Topics: Animals; Antimalarials; Atovaquone; Dapsone; Drug Synergism; Drug Therapy, Combination; Folic Acid Antagonists; Naphthoquinones; Plasmodium falciparum; Proguanil; Triazines | 2006 |
Population pharmacokinetic and pharmacodynamic modelling of the antimalarial chemotherapy chlorproguanil/dapsone.
Topics: Adolescent; Adult; Animals; Antimalarials; Child; Child, Preschool; Dapsone; Humans; Infant; Malaria, Falciparum; Middle Aged; Plasmodium falciparum; Proguanil; Prospective Studies; Triazines | 2006 |